Experts urge govt. to regulate medical implants

New Delhi : Given the ‘faulty hip implants’ of metal on the metal prosthesis, medical experts urged the government to establish a National Joint Replacement Registry to regulate medical implants and drugs for patients’ safety.

Raju Vaishya, a joint replacement surgeon, said that it is ironical that although about 4,700 patients received the ‘faulty hip implants’ in India, over 3,600 of them remain untraceable.

“Incidentally, there is no government body like National Joint Replacement Registry in our country, though the formation of such a body was suggested, many years ago. But, the Central Drugs Standard Control Organization (CDSCO) did not take any timely action on this matter, despite knowing the problems related to these implants since at least 2010. It is, therefore, a regulatory failure,” said Vaishya.

In Metal on Metal hip implants, the metal ball and the metal cup slide against each other during walking or running. Metal can also be released from other parts of the implant where two implant components connect. Metal release, thus, causes some tiny metal particles to wear off of the device into the space around the implant which may enter the bloodstream.

Atul Srivastava, Secretary, Indian Orthopaedic Association (IOA) also agreed to the idea of setting such a national body, which may be called National Joint Replacement Registry or National Healthcare Data Storage and Management Committee to stop the use of faulty implants or medical devices.

According to researchers, more catastrophic failures of medical implants and devices are “almost guaranteed” to happen because there have been no significant reforms on the way in India, which regulates medical implants.

  • Related Posts

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    STF busts fake meds racket spread across 6 states

    STF busts fake meds racket spread across 6 states